Entero Therapeutics Inc. (ENTO)
0.56
-0.01 (-2.61%)
At close: Jan 15, 2025, 11:46 AM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| Net Income | -15.79M | -14.63M | -58.54M | -32.67M | -15.18K | -13.53M | -11.10M | -14.59M | -5.93K | -2.95K | -1.01K |
| Depreciation & Amortization | 29.27K | 29.27K | 542.25K | 565.35K | 635.05 | 798.45K | 754.00K | 734.50K | 733.60 | 434.09 | 11.76 |
| Stock-Based Compensation | 1.04M | 769.12K | 1.37M | 549.42K | 1.39K | 2.84K | 2.02K | 603.75 | n/a | n/a | n/a |
| Other Working Capital | 2.26M | -8.42K | 15.13K | 12.82K | -444.66K | -265.52K | -37.87K | 572.84K | -14.83 | 497.03 | 1.04K |
| Other Non-Cash Items | 157.02K | 277.43K | 3.46M | 5.40M | 397.41 | 6.62M | 5.16M | 9.95M | 1.68K | 652.59 | -16.97 |
| Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Change in Working Capital | 2.19M | -10.50M | 17.10M | 14.15M | -1.28K | -1.71M | -268.20K | 704.87K | -652.93 | 853.29 | 1.08K |
| Operating Cash Flow | -12.38M | -22.34M | -32.29M | -11.22M | -14.03K | -10.87M | -7.18M | -4.53M | -4.17K | -1.01K | 56.55 |
| Capital Expenditures | -500.00K | n/a | -10.32M | -4.17K | -24.10K | -305.47K | -32.17K | -12.36K | -24.38 | -191 | n/a |
| Acquisitions | n/a | n/a | n/a | 91.52K | n/a | n/a | n/a | n/a | n/a | -560.95 | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | n/a | -10.25K | 91.52 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Investing Cash Flow | -500.00K | n/a | -10.32M | 87.35K | -24.1 | -305.47K | -32.17K | -12.36K | -24.38 | -751.96 | n/a |
| Debt Repayment | -603.49K | -641.24K | 88.83K | 2.86M | 3.61M | -190.68K | 1.00M | 1.89M | 5.02M | 991.00K | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 657.00 | -6.67M | 12.01M | 13.20M | 61.59K | n/a | n/a | -2.84M | -340.52K | n/a | -9.97 |
| Financial Cash Flow | 15.23M | 15.74M | 44.76M | 17.05M | 13.14K | 11.71M | 6.01M | 5.75M | 4.68K | 1.85K | -9.97 |
| Net Cash Flow | 2.35M | -6.86M | 2.19M | 5.89M | -938.55 | 540.87K | -1.20M | 1.77M | 447.78 | 85.65 | 48.23 |
| Free Cash Flow | -12.88M | -22.34M | -42.61M | -11.23M | -38.13K | -11.17M | -7.22M | -4.55M | -4.19K | -1.20K | 56.55 |